Tags

Type your tag names separated by a space and hit enter

Molecular regulation of articular chondrocyte function and its significance in osteoarthritis.
Histol Histopathol. 2011 03; 26(3):377-94.HH

Abstract

Osteoarthritis (OA) is the most common form of joint disease. Histopathologically, OA is characterized by a progressive loss of articular cartilage, osteophyte formation, thickening of subchondral bone, and subchondral cyst formation. All current therapies are aimed at symptomatic control and have limited impacts on impeding or reversing the histopathologic progression to advanced OA. Previous studies have shown that overexpression of matrix-degrading proteinases and proinflammatory cytokines is associated with osteoarthritic cartilage degradation. However, clinical trials applying an inhibitor of proteinases or proinflammatory cytokines have been unsuccessful. A more sophisticated understanding of the regulatory mechanisms that control the function of articular chondrocytes is paramount to developing effective treatments. Since multiple catabolic factors and pathological chondrocyte hypertrophy are involved in the development of OA, it is important to identify which upstream factors regulate the expression of catabolic molecules and/or chondrocyte hypertrophy in articular cartilage. This review summarizes the current studies on the molecular regulation, with a main focus on transcriptional regulation, of the function of adult articular chondrocytes and its significance in the pathogenesis and treatment of OA. Recent studies have discovered that transcription factor Nfat1 may play an important role in maintaining the physiological function of adult articular chondrocytes. Nfat1-deficient mice exhibit normal skeletal development but display most of the features of human OA as adults, including chondrocyte hypertrophy with overexpression of specific matrix-degrading proteinases and proinflammatory cytokines in adult articular cartilage. β-catenin transcriptional signaling in articular chondrocytes may also be involved in the pathogenesis of OA. Activation of β-catenin leads to OA-like phenotypes with overexpression of specific matrix-degrading proteinases in articular cartilage of adult mice. These and other regulatory mechanisms described in this review may provide new insights into the pathogenesis of OA and the development of novel therapeutic targets for the treatment of OA.

Authors+Show Affiliations

Harrington Laboratory for Molecular Orthopedics, Department of Orthopedic Surgery, University of Kansas Medical Center, Kansas City, KS, USA.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

21210351

Citation

Schroeppel, J P., et al. "Molecular Regulation of Articular Chondrocyte Function and Its Significance in Osteoarthritis." Histology and Histopathology, vol. 26, no. 3, 2011, pp. 377-94.
Schroeppel JP, Crist JD, Anderson HC, et al. Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. Histol Histopathol. 2011;26(3):377-94.
Schroeppel, J. P., Crist, J. D., Anderson, H. C., & Wang, J. (2011). Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. Histology and Histopathology, 26(3), 377-94. https://doi.org/10.14670/HH-26.377
Schroeppel JP, et al. Molecular Regulation of Articular Chondrocyte Function and Its Significance in Osteoarthritis. Histol Histopathol. 2011;26(3):377-94. PubMed PMID: 21210351.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. AU - Schroeppel,J P, AU - Crist,J D, AU - Anderson,H C, AU - Wang,J, PY - 2011/1/7/entrez PY - 2011/1/7/pubmed PY - 2011/4/26/medline SP - 377 EP - 94 JF - Histology and histopathology JO - Histol Histopathol VL - 26 IS - 3 N2 - Osteoarthritis (OA) is the most common form of joint disease. Histopathologically, OA is characterized by a progressive loss of articular cartilage, osteophyte formation, thickening of subchondral bone, and subchondral cyst formation. All current therapies are aimed at symptomatic control and have limited impacts on impeding or reversing the histopathologic progression to advanced OA. Previous studies have shown that overexpression of matrix-degrading proteinases and proinflammatory cytokines is associated with osteoarthritic cartilage degradation. However, clinical trials applying an inhibitor of proteinases or proinflammatory cytokines have been unsuccessful. A more sophisticated understanding of the regulatory mechanisms that control the function of articular chondrocytes is paramount to developing effective treatments. Since multiple catabolic factors and pathological chondrocyte hypertrophy are involved in the development of OA, it is important to identify which upstream factors regulate the expression of catabolic molecules and/or chondrocyte hypertrophy in articular cartilage. This review summarizes the current studies on the molecular regulation, with a main focus on transcriptional regulation, of the function of adult articular chondrocytes and its significance in the pathogenesis and treatment of OA. Recent studies have discovered that transcription factor Nfat1 may play an important role in maintaining the physiological function of adult articular chondrocytes. Nfat1-deficient mice exhibit normal skeletal development but display most of the features of human OA as adults, including chondrocyte hypertrophy with overexpression of specific matrix-degrading proteinases and proinflammatory cytokines in adult articular cartilage. β-catenin transcriptional signaling in articular chondrocytes may also be involved in the pathogenesis of OA. Activation of β-catenin leads to OA-like phenotypes with overexpression of specific matrix-degrading proteinases in articular cartilage of adult mice. These and other regulatory mechanisms described in this review may provide new insights into the pathogenesis of OA and the development of novel therapeutic targets for the treatment of OA. SN - 1699-5848 UR - https://www.unboundmedicine.com/medline/citation/21210351/Molecular_regulation_of_articular_chondrocyte_function_and_its_significance_in_osteoarthritis_ L2 - http://www.hh.um.es/Abstracts/Vol_26/26_3/26_3_377.htm DB - PRIME DP - Unbound Medicine ER -